WHO ICTRP trial
DU-6859a Pharmacokinetic Study in Human
ChiCTR-ONRC-13003287 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-ONRC-13003287 |
|---|---|
| Public title | DU-6859a Pharmacokinetic Study in Human |
| Scientific title | Pharmacokinetic Study on Sitafloxacin (DU-6859a) Tablets in Chinese Healthy Subjects |
| Primary sponsor | Huashan Hospital affiliated to Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | I (Phase I study) |
| Countries | China |
| Interventions | Low single-dose group:Sitafloxacin 50mg tablet p.o.;Middle single-dose group:Sitafloxacin 100mg tablet p.o.;High single-dose group:Sitafloxacin 200mg tablet p.o.;Multi-dose group:Sitafloxacin 100mg tablet BID p.o. for 7 days |
| Registration date | Apr 22, 2013 |
| Target size | Low single-dose group:12;Middle single-dose group:12;High single-dose… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: